D

DAFNA Capital Management, LLC

9 employees

Dafna Capital Management is an investment advisor that specializes in managing client portfolios of biotechnology companies.

Investor insights

Countries invested in

united states1

Sectors invested in

Biotechnology10
Pharmaceutical4
Therapeutics4
Health Care3
Biopharma3
Medical2
Clinical Trials2
Rare Diseases2
chronic inflammatory demyelinating polyneuropathy1
Genetics1
Health Diagnostics1
Neuroscience1
Women's1
Systemic Sclerosis1
systemic lupus erythematosus1
Cystic Fibrosis1
Dermatomyositis1
Fibrosis1
Orphan diseases1
Lupus1

Funding rounds participated in

$37M sweet spot round size

Most of their 10 investments are in rounds between $15M and $60M

Investor type

Venture Capital

Basic info

Industry

investment management

Sectors

biotechnology
medical devices
hedge fund
investments
healthcare

Date founded

1999

Investments made

K

KAHR-medical Ltd. raised $47M on June 16, 2021

Investors: Cancer Focus Fund, Hadasit Bio-Holdings Ltd., Flerie Invest, Peregrine Ventures and DAFNA Capital Management, LLC

G

Gemini Therapeutics raised $95M on February 8, 2021

Investors: Suvretta Capital Management LLC, OrbiMed Advisors, Foresite Capital, Lightstone Ventures, Atlas Venture, Wellington Management, Wu Capital (双湖资本) and DAFNA Capital Management, LLC

O

ObsEva SA raised $60M on October 10, 2017

Investors: Omega Funds, Aisling Capital, New Leaf Venture Partners, Venrock, Sofinnova Ventures, Russia technology fund and DAFNA Capital Management, LLC

A

Ardelyx, Inc. raised $110M on July 18, 2016

Investors: 上海市东方世纪消费品发展促进中心, Perceptive Advisors, Quadrille Capital, RA Capital Management, L.P. and DAFNA Capital Management, LLC

C

Corbus Pharmaceuticals raised $15M on June 10, 2016

Investors: Perceptive Advisors and DAFNA Capital Management, LLC

a

argenx raised $33M on June 3, 2016

Investors: Burrage Capital Management, Aquila Capital, MPM Capital and DAFNA Capital Management, LLC

M

Minerva Neurosciences raised $31M on March 24, 2015

Investors: HCP Ltd, Index Ventures, Perceptive Advisors and DAFNA Capital Management, LLC

C

Cascadian Therapeutics, Inc. raised $15M on September 24, 2010

Investors: Strauss & Partnere, Hartz Real Estate, Cowen Inc. and DAFNA Capital Management, LLC

R

Raptor Pharmaceuticals (Horizon Pharma PLC) raised $15M on August 9, 2010

Investors: Lincoln Park Capital, LLC and DAFNA Capital Management, LLC

C

Cancervax (merged to Micromet) raised $40M on October 3, 2008

Investors: Merlin Nexus, Index Ventures, Abingworth and DAFNA Capital Management, LLC

FAQ